Press Esc to close
Wednesday 24 May 2017
News updated at 2:06 AM IST

Tarnished image

May 30, 2013 : 22:53 IST
The serious fraud committed by Ranbaxy Laboratories, one of the country’s major pharmaceutical companies, has tarnished the image of the entire industry. The company has admitted charges of wrongdoing and adulteration in the US and has agreed to pay $ 500 in civil and criminal fine to the US department of justice in an out-of-court settlement.

It is one of the largest monetary settlements in the history of the pharmaceutical industry and still there is a view that the penalty should have been higher in view of the gravity of the offence. The company has been found to have resorted to bad manufacturing practices and adulteration of drugs, and it falsified data and test results to secure the approval of the US Food and Drug administration (FDA). One drug which it marketed in the US market was found to have been contaminated with glass powder.
What makes the case worse is that the malpractices were deliberate. The fraud came to light because of the efforts made by a whistleblower who was once a senior officer with the company. He had drawn the attention of the management to the malpractices but was told to cover up and destroy evidence. That shows that the wrongdoing was wilful. The fraud was exposed after he left the company and alerted the US authorities about the malpractices. The company was taken over in 2008 by a Japanese firm which is also planning to take legal action against the previous management. The fraud pre-dated the takeover. Fraud and deception in the case of drugs is much more serious than financial fraud.

The Ranbaxy fraud also exposes the lack of testing and checking in India of drugs produced in the country. There is neither a system nor adequate manpower for that and the regulatory practices are weak. It is believed that fake and substandard drugs are being sold widely. India’s pharmaceutical industry has done well recently and made a mark internationally for its range of products and their affordability. It has also become a major export industry. But its image has taken a bad knock with the Ranbaxy episode. The FDA has also banned import of drugs from a unit of another Indian drug company Wockhardt. Compromising on quality will only damage the industry’s credibility and future prospects.

Go to Top

Photo Gallery
Helpers attend to injured people inside the Manchester Arena...

Helpers attend to injured people inside the Manchester Arena...

South Korean army's K-55 self-propelled howitzer fires during the annual exercise in Paju

South Korean army's K-55 self-propelled howitzer fires during the annual exercise in Paju

President Donald Trump pauses as he makes a statement...

President Donald Trump pauses as he makes a statement...

Delhi Chief Minister Arvind Kejriwal at an interaction with...

Delhi Chief Minister Arvind Kejriwal at an interaction with...

A shopkeeper looks for valuables and documents in the debris...

A shopkeeper looks for valuables and documents in the debris...

HP State Electricity Board Employees Union members shout slogans...

HP State Electricity Board Employees Union members shout slogans...

Congress and CPM leaders, activists raise slogans against the West Bengal...

Congress and CPM leaders, activists raise slogans against the West Bengal...

Former Union Minister and senior Congress leader Mani Shankar Aiyar with Center for Peace...

Former Union Minister and senior Congress leader Mani Shankar Aiyar with Center for Peace...

In this NASA provided frame from video, NASA astronaut Jack Fischer...

In this NASA provided frame from video, NASA astronaut Jack Fischer...

Actor Brad Pitt gives his autographs for fans...

Actor Brad Pitt gives his autographs for fans...

Like us on Facebook

Copyright 2017, The Printers (Mysore) Private Ltd., 75, M.G Road, Post Box 5331, Bengaluru - 560001
Tel: +91 (80) 25880000 Fax No. +91 (80) 25880523
Powered by Yodasoft Technologies Pvt. Ltd.